Tan DS - Search Results

1

Effect of concomitant statin, metformin, or aspirin on rituximab treatment for diffuse large B-cell lymphoma.

Koo YX, Tan DS, Tan IB, Tai DW, Ha T, Ong WS, Quek R, Tao M, Lim ST. Koo YX, et al. Among authors: tan ib, tan ds. Leuk Lymphoma. 2011 Aug;52(8):1509-16. doi: 10.3109/10428194.2011.574752. Epub 2011 Jun 10. Leuk Lymphoma. 2011. PMID: 21651435

2

Primary tracheal lymphoma causing respiratory failure.

Tan DS, Eng PC, Lim ST, Tao M. Tan DS, et al. J Thorac Oncol. 2008 Aug;3(8):929-30. doi: 10.1097/JTO.0b013e318180271d. J Thorac Oncol. 2008. PMID: 18670314 Free article.

3

Risk of hepatitis B virus reactivation in patients who are hepatitis B surface antigen negative/antibody to hepatitis B core antigen positive and the role of routine antiviral prophylaxis.

Koo YX, Tan DS, Tan BH, Quek R, Tao M, Lim ST. Koo YX, et al. Among authors: tan ds, tan bh. J Clin Oncol. 2009 May 20;27(15):2570-1; author reply 2571-2. doi: 10.1200/JCO.2009.21.9352. Epub 2009 Apr 13. J Clin Oncol. 2009. PMID: 19364951 No abstract available.

4

Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.

Koo YX, Tan DS, Tan IB, Tao M, Lim ST. Koo YX, et al. Among authors: tan ib, tan ds. Ann Intern Med. 2009 May 5;150(9):655-6. doi: 10.7326/0003-4819-150-9-200905050-00024. Ann Intern Med. 2009. PMID: 19414854 No abstract available.

5

"Anti-HBc alone" in human immunodeficiency virus-positive and immuno-suppressed lymphoma patients.

Koo YX, Tan DS, Tan IB, Quek R, Tao M, Lim ST. Koo YX, et al. Among authors: tan ib, tan ds. World J Gastroenterol. 2009 Aug 14;15(30):3834-5. doi: 10.3748/wjg.15.3834. World J Gastroenterol. 2009. PMID: 19673031 Free PMC article.

6

Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.

Koo YX, Tan DS, Tan IB, Tao M, Chow WC, Lim ST. Koo YX, et al. Among authors: tan ib, tan ds. Cancer. 2010 Jan 1;116(1):115-21. doi: 10.1002/cncr.24742. Cancer. 2010. PMID: 19899164 Free article.

7

Truth about ERCC1 in lung cancer.

Tan DS, Ng QS, Tan IB, Lim ST, Lim WT. Tan DS, et al. Among authors: tan ib. J Clin Oncol. 2010 Apr 1;28(10):e162; author reply e164. doi: 10.1200/JCO.2009.26.6270. Epub 2010 Feb 16. J Clin Oncol. 2010. PMID: 20159806 No abstract available.

8

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST. Koo YX, et al. Among authors: tan ib, tan ds. Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26. Ann Hematol. 2011. PMID: 21520001

9

The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Ali R, Toh HC, Chia WK; ASCOLT Trial Investigators. Ali R, et al. Trials. 2011 Dec 14;12:261. doi: 10.1186/1745-6215-12-261. Trials. 2011. PMID: 22168568 Free PMC article. Clinical Trial.

10

Technical Validation of a Next-Generation Sequencing Assay for Detecting Actionable Mutations in Patients with Gastrointestinal Cancer.

Wang SR, Malik S, Tan IB, Chan YS, Hoi Q, Ow JL, He CZ, Ching CE, Poh DYS, Seah HM, Cheung KHT, Perumal D, Devasia AG, Pan L, Ang S, Lee SE, Ten R, Chua C, Tan DSW, Qu JZZ, Bylstra YM, Lim L, Lezhava A, Ng PC, Wong CW, Lim T, Tan P. Wang SR, et al. J Mol Diagn. 2016 May;18(3):416-424. doi: 10.1016/j.jmoldx.2016.01.006. Epub 2016 Mar 9. J Mol Diagn. 2016. PMID: 26970585 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

504 results

Search Page